Thomas Patrick Kelly's Net Worth
$6.29 Million
Who is Thomas Patrick Kelly?
Thomas Patrick Kelly has an estimated net worth of $6.29 Million. This is based on reported shares across multiple companies, which include Deciphera Pharmaceuticals, Inc., and CRITICAL THERAPEUTICS INC.
SEC CIK
Thomas Patrick Kelly's CIK is 0001410514
Past Insider Trading and Trends
2019 was Thomas Patrick Kelly's most active year for acquiring shares with 12 total transactions. Thomas Patrick Kelly's most active month to acquire stocks was the month of January. 2019 was Thomas Patrick Kelly's most active year for disposing of shares, totalling 25 transactions. Thomas Patrick Kelly's most active month to dispose stocks was the month of May. 2019 saw Thomas Patrick Kelly paying a total of $170,100.00 for 165,000 shares, this is the most they've acquired in one year. In 2019 Thomas Patrick Kelly cashed out on 180,000 shares for a total of $4,310,767.86, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Deciphera Pharmaceuticals, Inc. (DCPH) No price found
Chief Financial OfficerThomas Patrick Kelly used to own units in Common Stock but no longer holds any shares there. From 2017 to 2024 Thomas Patrick Kelly acquired a total of 260,148 shares in Deciphera Pharmaceuticals, Inc. at a cost of $238,140.00, Thomas also disposed a total of 260,148 shares of Deciphera Pharmaceuticals, Inc. equalling to $6,536,379.64.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -80.35K |
—
|
—
|
0
|
Jun 11
| |||
Form 4
| +21.59% | 14.27K |
$15.62 | -$47,009.28 | 80.35K |
Feb 15 - Feb 16
| |||
Form 4
| -3.55% | -2.44K |
$14.47 | -$35,233.96 | 66.08K |
Jan 16
| |||
Form 4
| +8.64% | 5.45K |
$15.37 | -$42,904.94 | 68.52K |
Dec 12 - Dec 13
| |||
Form 4
| +10.37% | 5.93K |
$12.02 | -$27,832.76 | 63.07K |
Oct 28 - Oct 30
| |||
Form 4
| -2.81% | -1.66K |
$14.40 | -$23,834.98 | 57.14K |
Jun 16
| |||
Form 4
| +34.61% | 15.12K |
$15.10 | -$20,685.63 | 58.8K |
Feb 15 - Feb 16
| |||
Form 4
| -5.21% | -2.40K |
$21.24 | -$51,042.84 | 43.68K |
Jan 17
| |||
Form 4
| -3.70% | -1.77K |
$10.75 | -$19,006.00 | 46.08K |
Jun 16
| |||
Form 4
| -2.78% | -1.37K |
$9.05 | -$12,380.40 | 47.85K |
Feb 16
| |||
Form 4
| +71.39% | 20.5K |
—
|
—
| 49.22K |
Jan 18
| |||
Form 4
| +63.01% | 11.1K |
—
|
—
| 28.72K |
Dec 15
| |||
Form 4
| +150.23% | 10.58K |
$48.87 | -$25,607.88 | 17.62K |
Feb 16
| |||
Form 4
|
—
|
0
|
$25.95 | -$144,366.30 | 7.04K |
Scheduled
|
Sep 14
| ||
Form 4
|
—
|
0
|
$24.06 | -$399,045.32 | 7.04K |
Scheduled
|
Sep 8 - Sep 10
| ||
Form 4
|
—
|
0
|
$28.54 | -$639,560.22 | 7.04K |
Scheduled
|
May 11
| ||
Form 4
|
∞
| 7.04K |
—
|
—
| 7.04K |
Feb 18
| |||
Form 4
|
—
|
0
|
$29.77 | -$669,061.26 |
0
|
Scheduled
|
Jan 2 - Jan 3
| ||
Form 4
|
—
|
0
|
$35.05 | -$2,652,768.00 |
0
|
Dec 23
| |||
Form 4
|
—
|
0
|
$20.95 | -$142,922.25 |
0
|
Scheduled
|
Oct 28
| ||
Form 4
|
—
|
0
|
$18.50 | -$372,177.46 | 19.41K |
Scheduled
|
Sep 11
| ||
Form 4
|
—
|
0
|
$21.58 | -$442,992.99 |
0
|
Scheduled
|
Aug 13
| ||
Form 4
|
—
|
0
|
$13.45 | -$4,090.47 |
0
|
Scheduled
|
Jun 19
| ||
Form 4
|
—
|
0
|
$13.55 | -$48,957.93 |
0
|
Scheduled
|
Jun 3
| ||
Form 4
|
—
|
0
|
$13.48 | -$34,134.81 |
0
|
Scheduled
|
May 21 - May 22
| ||
Form 4
|
—
|
0
|
$12.41 | -$284,008.95 |
0
|
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
$15.95 | -$42,165.00 |
0
|
Scheduled
|
Feb 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
$13.54 | -$116,450.00 |
0
|
Scheduled
|
Jan 7
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CRITICAL THERAPEUTICS INC No price found
CFO & SVP Finance & Corp. Dev,Thomas Patrick Kelly owns 90,700 units of Common Stock. In the year 2007 Thomas Patrick Kelly acquired a total of 90,700 shares in CRITICAL THERAPEUTICS INC at a cost of $8,406.30.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +62.84% | 35K |
—
| $35.00 | 90.7K |
Feb 14
| |||
Form 4
| +81.43% | 25K |
—
| $25.00 | 55.7K |
Nov 5
| |||
Form 4
| +14.98% | 4K |
$2.08 | $8,319.60 | 30.7K |
Aug 22
| |||
Form 4
|
∞
| 26.7K |
—
| $26.70 | 26.7K |
Aug 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||